René de Araújo Gleizer

Severe hemolytic anemia following high-dose intravenous immunoglobulin in myasthenia gravis: an underrecognized, but relevant adverse event

Case Presentation: A 37-year-old woman with acetylcholine receptor antibody–positive myasthenia gravis received high-dose intravenous immunoglobulin (2 g/kg over 5 days) due to progressive generalized weakness, mild left ptosis and myasthenic facies. She had no features of respiratory distress and was discharged after...